FRIBERG GREGORY R (EVP, Chief R&D Officer) sold 6.0% of their position (3.28K shares) of BIOMARIN PHARMACEUTICAL INC on the open market
Open‑market sale worth $176.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/11/2026ACC: 0001628280-26-033639
Officer· EVP, Chief R&D Officer
Since Feb 2026
-3.28K
Net shares
Net seller
$176.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.28K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.28K
Price / share
$53.85
Trade value
$176.68K
% of position
6.0%
5/7/2026
55.10K→51.82K
Total
Net shares
−3.28K
Net value
-$176.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/7/2026 | S · Sale | −3.28K | $53.85 | $176.68K | 6.0% | 55.10K | 51.82K |
| Total | −3.28K | -$176.68K | ||||||
Derivative Transactions0
No derivative transactions reported